Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Oct 1;92(3):269-72.
doi: 10.1007/BF00244471.

Founder effect in a Belgian-Dutch fragile X population

Affiliations

Founder effect in a Belgian-Dutch fragile X population

S Buyle et al. Hum Genet. .

Abstract

For many years, the high prevalence of the fragile X syndrome was thought to be caused by a high mutation frequency. The recent isolation of the FMR1 gene and identification of the most prevalent mutation enable a more precise study of the fragile X mutation. As the vast majority of fragile X patients show amplification of an unstable trinucleotide repeat, DNA studies can now trace back the origin of the fragile X mutation. To date, de novo mutations leading to amplification of the CGG repeat have not yet been detected. Recently, linkage disequilibrium was found in the Australian and US populations between the fragile X mutation and adjacent polymorphic markers, suggesting a founder effect of the fragile X mutation. We present here a molecular study of Belgian and Dutch fragile X families. No de novo mutations could be found in 54 of these families. Moreover, we found significant (P < 0.0001) linkage disequilibrium in 68 unrelated fragile X patients between the fragile X mutation and an adjacent polymorphic microsatellite at DXS548. This suggests that a founder effect of the fragile X mutation also exists in the Belgian and Dutch populations. Both the absence of new mutations and the presence of linkage disequilibrium suggest that a few ancestral mutations are responsible for most of the patients with fragile X syndrome.

PubMed Disclaimer

References

    1. Hum Mol Genet. 1992 Oct;1(7):467-73 - PubMed
    1. Hum Mol Genet. 1992 Oct;1(7):511-5 - PubMed
    1. Nat Genet. 1992 Jul;1(4):257-60 - PubMed
    1. Ann Hum Genet. 1984 Jan;48(Pt 1):21-37 - PubMed
    1. Cell. 1992 Feb 21;68(4):799-808 - PubMed

LinkOut - more resources